New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Baxter International Inc. (NYSE:BAX), Medtronic, Inc. (NYSE:MDT), Delcath Systems, Inc. (NASDAQ:DCTH)
Dynavax Technologies Corporation (NASDAQ:DVAX) declined -1.14%, trading on 4.42million shares, to end the trade at $1.74. The stock changed hands in a range of $1.69 to $1.78, bringing its market capitalization to about $456.97 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.98 and was moved to the maximum level of $3.33. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines.
Will DVAX Reach the Bottom after Yesterday’s Correction? Find Out Here
Baxter International Inc. (NYSE:BAX) declined -1.40%, to complete the trading session at $68.30, with a total volume of 4.41 million shares. The stock, on average, trades on a volume of 3.21million shares. It floated in a range of $68.25 to $68.78 during the last trading session, with a beta value of 0.56. Its market capitalization now moved to about $37.07 billion. In the past 52 weeks, the share price has not declined below $62.80 and above $74.60. Baxter International Inc. (Baxter,) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery.
Has BAX Found The Bottom and Ready To Move Up? Find Out Here
Medtronic, Inc. (NYSE:MDT) recorded a fall of -0.79% and was in a range of $56.11-$56.94 before closing at $55.56. The stock completed the day with a total volume of 4.40 million shares, versus an average volume of 5.04 million shares. The share price hit its 52-week low of $43.51 and $60.93 was the best price. Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies.
Has MDT Found The Bottom And Ready To Gain Momentum? Find Out Here
Delcath Systems, Inc. (NASDAQ:DCTH) declined -9.06% yesterday, bringing its market capitalization around $39.28 million. The share price, after opening at $0.33, made a high of $0.35 and hovered above $0.31 to end the day at $0.311. The total number of shares that changed hands during the session was 4.33 million shares, as compared to average trading volume of 6.32 million shares. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
Why Should Investors Buy DCTH After the Recent Fall? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)